Live feed08:05:00·1083dSECFilingvia QuantisnowCTI BioPharma Corp. (DE) filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.CTIC· CTI BioPharma Corp. (DE)Health CareOriginal source